`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`Minutes
`
`Team Members : (✓ = Present, *= part-time)
`
`MAN l t-31.Z LJMA 8
`Business Use Only
`
`Meeting Date: Oct. 1, 2012
`Meeting Notes Date: Oct. 1 o. 2012
`Author:
`Room: WSJ-340.3.09
`Dial-in:
`
`To-Team Members:(✓ = Present,*= part-time)
`
`Executive Summary
`•
`I
`I
`
`I
`I
`I
`I
`I
`I
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`1 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lead:
`
`Pre-reads
`
`None
`
`Closed
`
`Lead:
`
`Pre~reads
`
`None
`
`Oen
`
`Who -
`
`• Project update
`
`D.iscussion
`
`Achievements
`
`Issues
`What
`
`Actions
`
`Topic/Situation
`
`Discussion I Decisions
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`2 of 8
`
`CONTAINS CONFIDENT IAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085 .002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`3 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Actions
`
`I, Topic/Situation
`
`_.._ .............................. __._.c-.......c.."""'""" ....... ~ I -Le_a----1d: _
`
`I Pre-reads
`
`__ _,
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`4 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Discussion I Decision
`
`None
`
`Oen
`
`Who
`
`Closed
`
`When
`
`Achievements
`
`lss•ues
`What
`
`Actions
`What
`
`Topic/Situation
`
`Discussion
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`5 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`o en
`
`Closed
`
`Lead:
`
`Pre-reads
`
`0 n
`I
`
`Who
`I
`
`Closed
`
`When
`
`Achievements
`
`What
`
`Actions
`
`Topic/Situation
`
`Discussion
`
`What
`
`Actions
`What
`
`Achievements
`
`Issues
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`6 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085 .006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`What
`
`Actions
`
`1---iiiiiiiiiiiiiiiiiiiiiiiiiiiiiii[==
`
`Closed
`
`O n
`
`Who
`
`Discussion
`
`Achievements
`
`Issues
`What
`
`Actions
`
`Closed
`
`Open
`
`Wtio -
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`7 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Consolidated Action Plan
`
`What
`
`Who
`
`When
`
`TRD Subteam Meeting Minutes: Date of Meeting: October 1, 2012
`
`8 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2085.008
`Regeneron v. Novartis, IPR2021-00816
`
`